Compile Data Set for Download or QSAR
Found 256 with Last Name = 'pookot' and Initial = 'd'
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538576(CHEMBL4634092)copy SMILEScopy InChI
Affinity DataIC50: 0.160nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538560(CHEMBL4640002)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538571(CHEMBL4635160)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538572(CHEMBL4649132)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538575(CHEMBL4638458)copy SMILEScopy InChI
Affinity DataIC50: 0.320nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538562(CHEMBL4643330)copy SMILEScopy InChI
Affinity DataIC50: 0.380nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538578(CHEMBL4640729)copy SMILEScopy InChI
Affinity DataIC50: 0.390nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538579(CHEMBL4647217)copy SMILEScopy InChI
Affinity DataIC50: 0.440nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538582(CHEMBL4638998)copy SMILEScopy InChI
Affinity DataIC50: 0.780nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538570(CHEMBL4638573)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538563(CHEMBL4648116)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538564(CHEMBL4641569)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538583(CHEMBL4643112)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538577(CHEMBL4648623)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538567(CHEMBL4633860)copy SMILEScopy InChI
Affinity DataIC50: 1.5nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591075(CHEMBL5200118)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538569(CHEMBL4644317)copy SMILEScopy InChI
Affinity DataIC50: 2.10nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538581(CHEMBL4642862)copy SMILEScopy InChI
Affinity DataIC50: 2.40nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591046(CHEMBL5202342)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538568(CHEMBL4640563)copy SMILEScopy InChI
Affinity DataIC50: 3.40nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538565(CHEMBL4635798)copy SMILEScopy InChI
Affinity DataIC50: 4.60nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591066(CHEMBL5190023)copy SMILES
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591045(CHEMBL5209076)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591054(CHEMBL5179922)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538574(CHEMBL4638688)copy SMILEScopy InChI
Affinity DataIC50: 6.60nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538566(CHEMBL4632475)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591079(CHEMBL5196751)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591070(CHEMBL5208600)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538556(CHEMBL4646914)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591075(CHEMBL5200118)copy SMILES
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591081(CHEMBL5193210)copy SMILES
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591044(CHEMBL5202445)copy SMILES
Affinity DataIC50: 11nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538561(CHEMBL4642308)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591077(CHEMBL5201930)copy SMILES
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591072(CHEMBL5172690)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591065(CHEMBL5170361)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591066(CHEMBL5190023)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591065(CHEMBL5170361)copy SMILES
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591064(CHEMBL5199369)copy SMILES
Affinity DataIC50: 17nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591054(CHEMBL5179922)copy SMILES
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591064(CHEMBL5199369)copy SMILES
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591059(CHEMBL5195519)copy SMILES
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591063(CHEMBL5180017)copy SMILES
Affinity DataIC50: 21nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetC-C chemokine receptor type 4(Human)
RAPT Therapeutics

Curated by ChEMBL
LigandPNGBDBM374633(6-((3R,4S)-4-(Azepan-1-yl)-3-methylpiperidin-1-yl)...)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2571GCPPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591043(CHEMBL5199283)copy SMILES
Affinity DataIC50: 23nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591072(CHEMBL5172690)copy SMILES
Affinity DataIC50: 25nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538558(CHEMBL4641488)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargeteIF-2-alpha kinase GCN2(Human)TBA
LigandPNGBDBM50591063(CHEMBL5180017)copy SMILES
Affinity DataIC50: 25nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27H1PJSPubMed
TargetUbiquitin carboxyl-terminal hydrolase 7(Human)
RAPT Therapeutics, Inc.

Curated by ChEMBL
LigandPNGBDBM50538559(CHEMBL4642553)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:Inhibition of recombinant full length USP7 (unknown origin) using ubiquintin-rhodamine as substrate preincubated for 30 mins followed by substrate ad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XK8K2TPubMed
TargetC-C chemokine receptor type 4(Human)
RAPT Therapeutics

Curated by ChEMBL
LigandPNGBDBM374652(1-((R)-1-(2,4-Dichlorophenyl)ethyl)-6-((3R,4S)-4-(...)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:Antagonist activity at human CCR4 expressed in rat chem-5 cells assessed as inhibition of CCL22-induced calcium flux measured at 2.5 secs time interv...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2571GCPPubMed
Displayed 1 to 50 (of 256 total ) | Next | Last >>
Jump to: